CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Impact of proposed China biotech investment rules expected to be minimal, RBC says

By Reuters News

** US Treasury's proposed draft rule on biotech investment in China will have minimal sector impact, as larger cos can likely keep pursuing M&A while smaller ones retain access to more affordable ex-US assets, RBC Capital Markets analysts say

** Department announced proposed rules for screening investment in China and added biotechnology sector to legislation

** "The current wording...is broad enough to allow most deal making", RBC said, but flagged uncertainty as rules could become more restrictive or looser

** For companies with acquisitive history, e.g. Jazz Pharma JAZZ.O, they could focus resources on US M&A to avoid even potential Treasury scrutiny, brokerage says

** "While there may be persistent headline risk for companies like Legend Biotech LEGN.O and BeOne Medicines that are still sometimes painted as Chinese biotechs, we think the practical impacts are immaterial as ONC is domiciled in Switzerland and LEGN is Cayman domiciled"- RBC

** Brokerage added its data suggests China deal flow continues to grow, with H1 deals rising to 45 and the share of all licensed assets climbing from 5% in 2024 to 12% in 2026

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.